XORTX Therapeutics Inc (NASDAQ:XRTX) has seen 1.58 million shares traded in the last trading session. The company, currently valued at $5.42M, closed the last trade at $1.87 per share which meant it gained $0.35 on the day or 23.03% during that session. The XRTX stock price is -302.14% off its 52-week high price of $7.52 and 41.71% above the 52-week low of $1.09. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.2 million shares traded. The 3-month trading volume is 2.78 million shares.
XORTX Therapeutics Inc (NASDAQ:XRTX) trade information
Sporting 23.03% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the XRTX stock price touched $1.87 or saw a rise of 25.5%. Year-to-date, XORTX Therapeutics Inc shares have moved -19.05%, while the 5-day performance has seen it change 3.89%. Over the past 30 days, the shares of XORTX Therapeutics Inc (NASDAQ:XRTX) have changed 0.54%. Short interest in the company has seen 31275.0 shares shorted with days to cover at 0.07.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
XORTX Therapeutics Inc (XRTX) estimates and forecasts
The company’s shares have lost -39.68% over the past 6 months.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 26.21% over the past 5 years.
XRTX Dividends
XORTX Therapeutics Inc is expected to release its next earnings report in November this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
XORTX Therapeutics Inc (NASDAQ:XRTX)’s Major holders
Insiders own 3.35% of the company shares, while shares held by institutions stand at 6.37% with a share float percentage of 6.59%. Investors are also buoyed by the number of investors in a company, with XORTX Therapeutics Inc having a total of 6.0 institutions that hold shares in the company.
